23.69

0.34% 0.08

After Hours: 23.69

Ceribell Inc (CBLL)

Overview News Price History Discussions Forecast

Ceribell Inc stock is traded at $23.69, with a volume of 305.32K. It is up +0.34% in the last 24 hours and down -4.51% over the past month. CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Previous Close:

$23.61

Open:

$24.18

24h Volume:

305.32K

Relative Volume:

0.81

Market Cap:

$909.18M

Revenue:

$95.07M

Net Income/Loss:

$-60.37M

P/E Ratio:

-14.54

EPS:

-1.6291

Net Cash Flow:

$-50.92M

1W Performance:

+0.00%

1M Performance:

-4.51%

6M Performance:

+27.57%

1Y Performance:

+100.59%

1-Day Range:

$23.32

$24.19

1-Week Range:

$23.32

$25.25

52-Week Range:

$10.85

$25.63

Ceribell Inc Stock (CBLL) Company Profile

Name

Ceribell Inc

Sector

Healthcare (1064)

Industry

Medical Devices (138)

Phone

(800) 436-0826

Address

360 N. PASTORIA AVENUE, SUNNYVALE

Employee

300

Twitter

Next Earnings Date

2026-11-03

Latest SEC Filings

CBLL's Discussions on Twitter

Compare CBLL vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CBLL Ceribell Inc	23.69	909.18M	95.07M	-60.37M	-50.92M	-1.6291
ABT Abbott Laboratories	97.50	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	86.38	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	275.43	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	42.60	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.15	49.74B	6.30B	1.07B	1.09B	1.8406

Ceribell Inc Stock (CBLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-21-25	Initiated	Raymond James	Strong Buy
Jun-24-25	Initiated	BTIG Research	Buy
Apr-04-25	Initiated	Ladenburg Thalmann	Buy
Nov-05-24	Initiated	BofA Securities	Buy
Nov-05-24	Initiated	Canaccord Genuity	Buy
Nov-05-24	Initiated	JP Morgan	Overweight
Nov-05-24	Initiated	TD Cowen	Buy
Nov-05-24	Initiated	William Blair	Outperform

View All

Ceribell Inc Stock (CBLL) Latest News

Oct 01, 2026

Form 144 Ceribell For: 1 October By Investing.com - Investing.com Canada

Oct 01, 2026

Ceribell Officer Raymond Woo Files Form 144 for Proposed Sale of 4,887 Shares - Kalkine Media

Oct 01, 2026

CeriBell: FDA Clearances And Delirium Expansion Could Create A New Growth Driver - Seeking Alpha

Oct 01, 2026

Sep 30, 2026

Ceribell receives FDA clearance for new EEG software features - Investing.com

Sep 30, 2026

Ceribell receives FDA clearance for new EEG software features By Investing.com - Investing.com South Africa

Sep 30, 2026

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis - GlobeNewswire

Sep 30, 2026

Sep 21, 2026

Ceribell stock price target reiterated at $30 by BTIG on growth outlook - Investing.com Nigeria

Sep 21, 2026

BTIG Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $30 - Moomoo

Sep 21, 2026

Sep 18, 2026

Blumberg Scott Executes 846 Ceribell Options and Disposes Shares on September 15, 2026 - Kalkine Media

Sep 18, 2026